Literature DB >> 15641148

Effect of 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol hydrochloride (FTY 720) on immune liver injury in mice.

Jing-Hua He1, Hui-Na Zhang, Zhi-Bin Lin.   

Abstract

AIM: To investigate the protective effect against two immune liver injury models in mice by 2-amino-2-(2-(4-octylphenyl) ethyl) propane-1,3-diol hydrochloride and its possible mechanisms in Con A-induced liver damage.
METHODS: Liver tissue or hepatocyte injury was monitored biochemically by measuring alanine aminotransferase (sALT) and aspartate aminotransferase (sAST) activity. Hematoxylin and eosin (HE) staining was used for histopathological examination. To evaluate the role of IFN-gamma and IL-4 in the liver injury, serum levels of IFN-gamma and IL-4 were determined using commercially available ELISA kit at 12 h after Con A challenge. We also determined FTY 720-induced spleen cell apoptosis by flow cytometry analysis or spleen cell proliferation test.
RESULTS: Different doses of FTY 720 treatment dramatically reduced circulating markers of hepatocyte injury in two kinds of immunological liver injury models. FTY 720 dramatically reduced the elevated serum IFN-gamma and IL-4 levels after Con A injection. Effect of spleen cell supernatants treated with Con A or FTY 720 on hepatocytes showed that ALT activities in cultured hepatocyte supernatants in Con A treatment group increased markedly and FTY 720 could reduce this elevated ALT activities in FTY 720 treatment group. FTY 720 dose-dependently increased the percentage of apoptotic cells in T cells and inhibited splenocyte proliferation induced by Con A.
CONCLUSION: Pretreatment with FTY 720 was shown to produce protective effect on the immune liver injury in mice. The possible mechanism of FTY 720 on Con A-induced liver damage is that it could inhibit lymphocyte proliferation and induce lymphocyte apoptosis, resulting in the reduction of IL-4 or IFN-gamma release, and subsequently protecting liver from being damaged by Con A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15641148      PMCID: PMC4250813          DOI: 10.3748/wjg.v11.i4.573

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice.

Authors:  X L Zhang; Q Z Quan; Z Q Sun; Y J Wang; X L Jiang; D Wang; W B Li
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 2.  Cytokines in the liver.

Authors:  G Ramadori; T Armbrust
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

3.  FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury.

Authors:  D Anselmo; F F Amersi; X-D Shen; F Gao; M Katori; B Ke; C Lassman; A J Coito; V Brinkmann; R W Busuttil; J W Kupiec-Weglinski; D G Farmer
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

4.  Immunosuppressive effect of FTY 720 on autoimmune diabetes models.

Authors:  H Yan; K Suzuki; X K Li; H Amemiya; S Suzuki; K Hiromitsu
Journal:  Transplant Proc       Date:  1998-11       Impact factor: 1.066

5.  A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes.

Authors:  S Suzuki; X K Li; S Enosawa; T Shinomiya
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

6.  FK506, but not cyclosporin A, prevents mitochondrial dysfunction during hypoxia in rat hepatocytes.

Authors:  M Kaibori; T Inoue; W Tu; M Oda; A H Kwon; Y Kamiyama; T Okumura
Journal:  Life Sci       Date:  2001-05-25       Impact factor: 5.037

7.  Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720.

Authors:  Y Hozumi; E Kobayashi; M Miyata; A Fujimura
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

8.  Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.

Authors:  T Nishikage; S Seki; S Toyabe; T Abo; Y Kagata; T Iwai; H Hiraide
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

9.  Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis.

Authors:  Sompol Permpongkosol; Jing-Ding Wang; Shiro Takahara; Kiyomi Matsumiya; Norio Nonomura; Kazuo Nishimura; Akira Tsujimura; Apichat Kongkanand; Akihiko Okuyama
Journal:  Int J Cancer       Date:  2002-03-10       Impact factor: 7.396

10.  Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.

Authors:  F Gantner; M Leist; A W Lohse; P G Germann; G Tiegs
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

View more
  3 in total

1.  Protective effect of FTY720 on several markers of liver injury induced by concanavalin a in mice.

Authors:  Xiao-Dong Yin; Pei-Jie Jia; Yan Pang; Jing-Hua He
Journal:  Curr Ther Res Clin Exp       Date:  2012-09

2.  Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro.

Authors:  P J Zhou; H Wang; G H Shi; X H Wang; Z J Shen; D Xu
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

3.  FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology.

Authors:  Kunitomo Adachi; Kenji Chiba
Journal:  Perspect Medicin Chem       Date:  2007-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.